The annual AusBiotech national conference, which attracts over 1400 delegates from across the world each year, is renowned for its agenda-setting programs, significant business analysis and world-class Business Matching Program.
This year, the conference program seeks to address the topical and challenging aspects of doing business in the key biotechnology sectors and driving partnering opportunities. AusBiotech 2010 will again see leading representatives from the global biotechnology industry, together with investors and business development professionals.
Following its success last year, AusBiotech 2010 will again be preceded by AusBiotech’s Australasian Life Sciences Investment Summit, an invitation-only, one-day event which showcases the high calibre of investment potential in Australia’s biotechnology industry to international investors.
EVENT DETAILS
Event: AusBiotech 2010 Date: Tuesday 19 October 2010 – Friday 22 October 2010 Venue: Melbourne Exhibition Centre 2 Clarendon Street Melbourne Victoria 3006 AUSTRALIA
The attendance of prominent biotech individuals from across the sector at AusBiotech 2010 offers key networking and partnering opportunities and provides insights and inspiration on the major trends affecting the industry. The event has grown year on year, with AusBiotech 2009 attracting 1423 delegates and 1983 conference participants.
Amongst the long and illustrious list of local and international session speakers throughout the conference, AusBiotech 2010 will see the following plenary speakers:
• Mr James C. Greenwood, President and CEO, Biotechnology Industry Organization, Washington D.C., United States • Dr David Nicholson, Senior Vice President, Worldwide Licensing and Knowledge Management, Merck Worldwide Laboratories, New Jersey, United States • Dr Bonnie Bain, Global Research and Analysis Director, Datamonitor Healthcare, United States For additional event information visit the conference website at: www.ausbiotech2010.com.au.
About AusBiotech AusBiotech is Australia’s voice on biotechnology, and represents more than 3,000 members, encompassing medicines, medical diagnostics and devices, agriculture, alternative fuels and climate change.
For further information, interviews, or media registration for AusBiotech 2010, please contact:
Jessica Sealby Buchan Consulting P: +61 3 9237 2800 E: jsealby@bcg.com.au
